Insulet Stands Out as a Mid-Cap Growth Pick While Genuine Parts and Deckers Face Headwinds

Industry
โดย StockStory·Read original
Summary · why it matters

StockStory highlights Insulet as a mid-cap stock with massive growth potential while questioning Genuine Parts and Deckers. Insulet, with a market cap of $10.33 billion, posted constant currency growth averaging 26.8% over the past two years and saw its free cash flow margin jump by 25.8 percentage points over five years. In contrast, Genuine Parts, valued at $14.07 billion, recorded below-average annual revenue increases of 3.1% over three years and an operating margin of 4.5% that trails the industry. Deckers, at a $15.88 billion market cap, showed subpar constant currency growth and a forecasted 5.1 percentage point decline in free cash flow margin.

Impact on stocks 3

Consumer Discretionary▼ · 2 stocks
Deckers Outdoor Corporation
DECK
▼ NegativeDemandrelevance

Subpar constant currency growth and forecasted decline in free cash flow margin indicate weak demand and profitability.

Genuine Parts Co
GPC
▼ NegativeDemandrelevance

Below-average revenue growth and low operating margin suggest weak demand and competitive pressure.

Biotech & Genomic Medicine▲ · 1 stocks
Insulet Corporation
PODD
▲ PositiveDemandrelevance

Strong constant currency growth and improving free cash flow margin indicate robust demand and operational efficiency.

© 2026 MarketDXNews